UNSPSC 51182044: Quinbolone

This classification denotes an anabolic steroid with the molecular formula C24H32O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W59598KWLX, chemically known as 17beta-(1-cyclopentenyloxy)-1,4-androstadien-3-on but generally known as quinbolone, which bears US NIH Compound Identifier 17214. European Medicines Agency schedules Quinbolone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10204MIG.

UNSPSC 51182044 Quinbolone is a Commodity code for a specific pharmaceutical active ingredient, but the recent state and local procurement activity under this code centers on generic multi-source pharmaceuticals and over-the-counter products supplied through cooperative purchasing agreements rather than quinbolone directly. State and local governments procure generic drugs and OTC products via multistate cooperative contracts that establish pricing, supply chain compliance, and distribution relationships with authorized wholesalers. The issuing bodies are primarily state departments of administration and cooperative purchasing alliances serving multiple states and local government facilities, including health departments, correctional facilities, and other public health entities. Solicitations require vendors to hold current Good Manufacturing Practices certification, Drug Supply Chain Security Act compliance, commercial liability insurance of $5 million per occurrence, and maintain contractual relationships with specified authorized wholesalers including AmerisourceBergen Drug Corporation (Cencora), Cardinal Health, and Morris & Dickson Co., LLC, with all products subject to FDA requirements and minimum shelf-life standards.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP (S1070000015802) on January 20, 2026 for generic multi-source pharmaceuticals and OTC products with a response date of March 26, 2026. This cooperative vehicle serves participating state and local government facilities across Minnesota and Oregon, among other states. MMCAP's procurement weighted evaluation at 75 percent on price competitiveness, 10 percent on fixed pricing for the contract term, and the remainder on EDI capability, administrative compliance, and acceptance of a 3 percent administrative fee. Awarded vendors receive contracts effective July 1, 2026 with a two-year term and optional extensions, with performance penalties ranging from $200 to $1,500 per violation for late reporting, missed onboarding, or improper class-of-trade denials. The solicitation does not disclose specific award values or budget ranges.